×
About 2,933 results

ALLMedicine™ Hepatitis E Center

Research & Reviews  1,115 results

Serum superoxide dismutase level is a potential biomarker of disease prognosis in patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742945
BMC Gastroenterology; He Y, Wang F et. al.

Jan 11th, 2022 - Viral hepatitis E clinically ranges from self-limiting hepatitis to lethal liver failure. Oxidative stress has been shown to mediate hepatic inflammation during HBV-induced liver failure. We investigated whether a biomarker of oxidative stress may...

An Evaluation of Hepatitis E Virus Molecular Typing Methods.
https://doi.org/10.1093/clinchem/hvab186
Clinical Chemistry; Baylis SA, Adlhoch C et. al.

Dec 31st, 2021 - Hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Better understanding of HEV subtypes involved in hepatitis E infections is essential. Investigation of sources and routes of transmission and the identification of potential cluste...

Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714212
Emerging Infectious Diseases; Bes M, Costafreda MI et. al.

Dec 22nd, 2021 - Hepatitis E virus (HEV) is the major cause of acute viral hepatitis in several countries in Europe. HEV is acquired mainly by consumption of contaminated pork but can also be transmitted through blood transfusion. HEV infection is usually self-lim...

The Clinical Cure Project of Chronic Hepatitis B in China
https://clinicaltrials.gov/ct2/show/NCT04035837

Dec 22nd, 2021 - Chronic hepatitis B is a global public health problem, with nearly 700,000 deaths each year because of hepatitis B-related diseases. Recent studies have found that some patients who have used nucleot(s)ide analogues(NAs) for some period can achiev...

Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling.
https://doi.org/10.1016/j.antiviral.2021.105228
Antiviral Research; Li Y, Li P et. al.

Dec 21st, 2021 - Hepatitis E virus (HEV) infection can cause severe acute hepatitis in pregnant women and chronic infection in immunocompromised patients, promoting the development of effective antiviral therapies. In this study, we identified niclosamide, a widel...

see more →

Clinicaltrials.gov  12 results

The Clinical Cure Project of Chronic Hepatitis B in China
https://clinicaltrials.gov/ct2/show/NCT04035837

Dec 22nd, 2021 - Chronic hepatitis B is a global public health problem, with nearly 700,000 deaths each year because of hepatitis B-related diseases. Recent studies have found that some patients who have used nucleot(s)ide analogues(NAs) for some period can achiev...

Impact of COVID-19 Infection During Pregnancy
https://clinicaltrials.gov/ct2/show/NCT05139953

Dec 1st, 2021 - COVID-19, caused by SARS-COV-2, was first reported in the city of Wuhan, Hubei province, China, at the end of December 2019. The exact origin of human infection has not yet been clearly identified.SARS-CoV-2 is a member of the Coronavirus family, ...

Mirasol Evaluation of Reduction in Infections Trial
https://clinicaltrials.gov/ct2/show/NCT03737669

Oct 6th, 2021 - Anemic patients from Mulago Hospital Complex who require fresh whole blood transfusion and with any of the following conditions will be considered for recruitment: cancer, general medical or surgical, obstetric hemorrhage, and/or sickle cell. Elig...

Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
https://clinicaltrials.gov/ct2/show/NCT04670419

Dec 17th, 2020 - Study objectives 1.1. Primary objectives: To examine viral factors, such as gt, subtype and viral load, associated with the morbidity and mortality of HEV infections in Belgium. 1.2. Secondary objectives: To describe host factors associated with t...

Hyperimmune Plasma for Patients With COVID-19
https://clinicaltrials.gov/ct2/show/NCT04614012

Nov 3rd, 2020 - Apheresis from recovered donors will be performed with a cell separator device , with 500-600 mL of plasma obtained from each donor. Donors are males and womens , age 18 yrs or more, evaluated for transmissible diseases according to the italian la...

see more →

News  45 results

Baricitinib and Infections: What's the Risk?
https://www.medpagetoday.com/rheumatology/arthritis/88120

Aug 17th, 2020 - Patients with rheumatoid arthritis treated with baricitinib (Olumiant) were at increased risk for infection in a dose-dependent manner, a review of data from eight double-blind randomized trials and one long-term extension study found. The inciden...

Hepatitis E
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/285310

Hepatitis A, B, C, D and what? You're probably not familiar with this one. Visit the CDC Disease of the Week to learn more.

Acute Hepatitis E Superinfection Reactivates Chronic HBV
https://www.mdedge.com/fedprac/article/168758/hepatitis/acute-hepatitis-e-superinfection-reactivates-chronic-hbv
Jan Dyer

Jun 26th, 2018 - Many things can reactivate chronic hepatitis B virus (HBV) infection—withdrawal of antiviral therapy, pregnancy, and chemotherapy, to name a few. So when a patient with stable chronic HBV virus presented with significant hepatitis flare, clinician.

New Clinical Practice Guidelines, June 2018 Edition
https://www.medscape.com/viewarticle/897693

Jun 7th, 2018 - In This Issue Read the latest updates to clinical practice guidelines and recommendations. View Key Guidelines for June 2018: Alcohol-Related Liver Disease Deprescribing Benzodiazepines for Insomnia Hepatitis E Essential Diagnostic Tests Colorecta...

Viral Hepatitis Overview: Osmosis Study Video
https://www.medscape.com/viewarticle/895006

Apr 20th, 2018 - What is the hepatitis virus? Well, the hepatitis virus invades liver cells and causes inflammation in the liver tissue. Five hepatitis viruses are recognized: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. They all have sligh...

see more →

Patient Education  1 results see all →